Skip to content Skip to footer

Optimizing Life Sciences CRM: A Candid Conversation with Akshay Kapadia from Conexus Solutions 

Shots: As life sciences organizations increasingly adopt integrated data, AI, and advanced analytics, CRM platforms are becoming powerful tools to anticipate customer needs, personalize engagements, and measure impact in real-time across multiple channels   In the coming years, CRM will transform into a strategic intelligence hub, empowering teams to make data-driven decisions and helping companies…

Read more

Breaking New Ground in Oncology: Leonard Mazur from Citius Pharmaceuticals in Conversation with PharmaShots 

Shots:  Citius Pharmaceuticals celebrates its first-ever FDA approval with Lymphir, a novel therapy for relapsed or refractory cutaneous T-cell lymphoma    In an exclusive conversation, Leonard Mazur, Co-Founder and CEO at Citius Pharmaceuticals, shares insights on Lymphir’s launch strategy and its potential impact on the oncology landscape   Leonard also highlights Mino-Lok, Citius’ innovative…

Read more

The Rise of Industrial Metaverse: Smarter Pharma Starts at AUTOMA+ 2025 

Digital transformation of the pharmaceutical industry is moving beyond buzzwords to real-world impact. At the Pharmaceutical Automation & Digitalisation Congress AUTOMA+ 2025 (24-25 November, Vösendorf, Austria), pharma leaders, including ZETA GmbH, Takeda and Sapio Sciences, are going to showcase how cutting-edge technologies, from digital twins and predictive analytics to minimal code platforms and AI-driven process…

Read more

Know Your Investor: Cormorant Asset Management (September’25 Edition) 

Shots: Welcome to the September edition of Know Your Investor, featuring leading investors fuelling healthcare & life sciences This edition spotlights Cormorant Asset Management, an investment firm focused on biotechnology and healthcare companies In 2024, Cormorant completed 31 investments ~$3.88B, spanning PIPEs, private financings, IPO, and venture rounds. For the full report, contact us at…

Read more

Know Your Investor: Venrock Healthcare Capital Partners (August’25 Edition)   

Shots:    Welcome to the August edition of Know Your Investor, featuring leading venture capital firms fuelling innovation in healthcare and life sciences This edition spotlights Venrock Healthcare Capital Partners, a venture capital fund focused on investments in both publicly and privately held healthcare companies In 2024, Venrock Healthcare Capital Partners invested approximately $4.56B across six…

Read more

Know Your Investor: Alexandria Venture (May’25 Edition)

Know Your Investor: Alexandria Venture (May’25 Edition)

Shots:    Welcome to the 2025 edition of Know Your Investor, spotlighting leading venture capital firms driving innovation in healthcare. This edition features Alexandria Venture Investments, a firm committed to supporting disruptive life science companies that aim to improve human health. In 2024, the firm invested approximately $2.7B across six public and private funding rounds, adding…

Read more

Know Your Investor RA Capital Management (January’25 Edition)

Know Your Investor: RA Capital Management (January’25 Edition)

Shots:   The January Edition features RA Capital Management, a global multi-stage investment firm dedicated to healthcare and life sciences In 2024, RA Capital added 74 companies to its portfolio, investing approximately $8.5B across seven funding rounds, including private and common funding Welcome to the 2025 series of Know Your Investor, a meticulously crafted report highlighting…

Read more

Know Your Investor (June Edition): Google Ventures

Know Your Investor (June Edition): Google Ventures

Shots:Google Ventures is an investment arm of Alphabet Inc. That invests profusely in seed-stage companies ranging from software and internet to healthcare, life sciences, and artificial intelligence among othersEver since 2016, GV pivoted to focusing on established companies. The company manages assets worth $10B and 400 active portfolio companies spanning across North America…

Read more